Discover the latest treatments for heart disease. From generic competition to innovative solutions, find out how the industry is evolving.
![Beating the Odds: Next-Gen Therapies in Heart Disease](https://btpimg.s3.us-east-2.amazonaws.com/wp-content/uploads/2024/07/22143707/cardiac-1080x675.jpg)
SCIENCE MADE SIMPLE
Stay Updated! Subscribe to The Primer
Share
Discover the latest treatments for heart disease. From generic competition to innovative solutions, find out how the industry is evolving.
Biological drugs — composed of proteins produced by living cells — have become some of the safest, most effective therapeutics in the pharmaceutical industry.
Understand the process of drug metabolism and how our bodies respond to medication at a cellular level.
Learn about the global regulatory process when bringing new medications to the market, from the FDA to other governing bodies.
Epigenetics refers to the study of changes in gene activity that occur without altering the underlying DNA sequence. Epigenetic changes…
The market for peptide therapies is rapidly becoming a pivotal area in precision medicine.
PARP1 inhibitors are back in the headlines after Astra Zeneca’s (Cambridge, England) and Merck’s (Kenilworth, New Jersey) Lynparza approval by FDA to treat pancreatic cancer patients based on the positive Phase III results. Pancreatic cancer is a notoriously difficult...
No question about it, Huntington’s disease (HD) is cruel. In the beginning, sufferers of this fatal neurodegenerative disorder experience involuntary movement and mood disturbance, most often in the form of depression. As the disease progresses, patients lose the...
We previously focused on the final stage of clinical testing, Phase III trials, where drug developers assess the safety and efficacy of their drug in large patient groups. At the end of Phase III, drug developers face the moment of truth: does the study data support...
Our recent article explored the riskiest part of the human clinical trials pathway: Phase II. About 70% of drugs that enter Phase II never make it out. Most often, it’s because they fail to demonstrate effectiveness. Even making it to Phase III is no guarantee of...
Biotech Primer is your go-to source for interactive training across the biotechnology, pharmaceutical, molecular diagnostics, and medical device sectors. Explore a range of in-depth biotech courses designed to deepen your understanding of key principles and applications in the field.